1. Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?

   • Jonathan S. Zager
   • Alexander C. J. van Akkooi

   Aso Perspectives 15 December 2022 Pages: 1279 - 1281

2. Predicting Recurrence Patterns Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma

   • Gabriel D. Ivey
   • Chen Hu
   • Jin He

   Hepatobiliary Tumors 22 November 2022 Pages: 1282 - 1284

3. Comparing Apples to Oranges: Commentary on a Secondary Analysis of SWOG 0809

   • Susanne G. Warner
   • Patrick Starlinger

   Hepatobiliary Tumors 15 December 2022 Pages: 1285 - 1286

4. Volume-Outcome for Pancreatic Cancer: Finally Getting Under the Hood

   • Meredith C. Mason
   • Nader N. Massarweh

   Pancreatic Tumors 15 December 2022 Pages: 1287 - 1289

5. Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?

   • Eloise Chapman-Davis
   • Emily M. Webster
   • Kevin Holcomb

   Gynecologic Oncology 08 November 2022 Pages: 1290 - 1292

6. Is Less Really More? Sublobar Resection in the Elderly

   • Brian Mitzman

   Thoracic Oncology 05 December 2022 Pages: 1293 - 1294

7. From NLR to TIN: What Can’t Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?

   • Nathaniel Deboever
   • Wayne L. Hofstetter

   Translational Research 06 January 2023 Pages: 1295 - 1296

8. Factors to Consider in Surgical Resection of Pulmonary Metastatic Carcinoma

   • Ke-Neng Chen

   Colorectal Cancer 11 January 2023 Pages: 1297 - 1298

9. Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)

   • Stephanie N. Gregory
   • A. Leila Sarvestani
   • Sunil Gupta

   ASO Research Letter 18 November 2022 Pages: 1299 - 1301

   

10. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

    • Carrie E. Ryan
    • Areeba Saif
    • Heloisa Soares

    Aso Research Letter 06 December 2022 Pages: 1302 - 1304

    

11. Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

    • Nathaniel B. Verhagen
    • Nicolas K. Koerber
    • On behalf of the N3C Consortium

    Aso Research Letter 07 December 2022 Pages: 1305 - 1308

    

12. Magnetic-Guided Occult Lesion Localization (M-GOLL): An Exploratory Feasibility Study of Preoperative CT-Guided Puncture and Intraoperative Magnetic Seed Localization for Minimally Invasive Surgical Resection of Non-palpable Pulmonary Lesions

    • J. A. González García
    • E. I. Rodríguez Alvarado
    • A. Gregorio Hernández

    Aso Research Letter 12 December 2022 Pages: 1309 - 1311

    

13. Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers

    • Nina M. Clark
    • Emma A. Roberts
    • Meghan R. Flanagan

    Global Health Services Research 05 November 2022 Pages: 1312 - 1326

    

14. ASO Author Reflections: Low Genetic Testing Utilization Among Patients with Breast, Ovarian, Pancreatic, and Prostate Cancers

    • Nina M. Clark
    • Meghan R. Flanagan

    ASO Author Reflections 02 November 2022 Pages: 1327 - 1328

15. ASO Visual Abstract: Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers

    • Nina M. Clark
    • Emma A. Roberts
    • Meghan R. Flanagan

    ASO Visual Abstract 22 November 2022 Pages: 1329 - 1330

16. Health-Related Quality of Life Following Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases

    • C. D. Griffiths
    • P. Karanicolas
    • P. E. Serrano

    Global Health Services Research 09 November 2022 Pages: 1331 - 1338

    

17. ASO Visual Abstract: Application and Match Rates in the Complex General Surgical Oncology Match

    • Jason Silvestre
    • Jessica R. Smith
    • Rachel R. Kelz

    ASO Visual Abstract 18 November 2022 Pages: 1339 - 1339

18. Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    Hepatobiliary Tumors 27 August 2022 Pages: 1340 - 1349

    

19. ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    ASO Author Reflections 25 August 2022 Pages: 1350 - 1351

20. ASO Visual Abstract: Application of Hazard Function to Investigate Recurrence of Intrahepatic Cholangiocarcinoma After Curative-Intent Liver Resection: A Novel Approach to Characterize Recurrence

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    ASO Visual Abstract 19 September 2022 Pages: 1352 - 1353

21. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

    • Sepideh Gholami
    • Sarah Colby
    • Flavio G. Rocha

    Hepatobiliary Tumors 09 January 2023 Pages: 1354 - 1363

    

22. ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers – Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

    • Sepideh Gholami
    • Sarah Colby
    • Flavio G. Rocha

    Aso Visual Abstract 21 December 2022 Pages: 1364 - 1365

23. The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-World Multicentric Analysis

    • Tingting Qin
    • Min Wang
    • Minimally Invasive Pancreas Treatment Group in the Pancreatic Disease Branch of China’s International Exchange and Promotion Association for Medicine and Healthcare

    Hepatobiliary Tumors Open access 22 October 2022 Pages: 1366 - 1378

    

24. ASO Visual Abstract: The Long-Term Outcome of Laparoscopic Resection for Perihilar Cholangiocarcinoma Compared with the Open Approach: A Real-world, Multicentric Analysis

    • Tingting Qin
    • Min Wang
    • Minimally Invasive Pancreas Treatment Group in the Pancreatic Disease Branch of China’s International Exchange and Promotion Association for Medicine and Healthcare

    ASO Visual Abstract 05 January 2023 Pages: 1379 - 1380

25. Left-sided Hepatectomy Leads to Less Postoperative Liver Failure and Comparable Overall Survival to Right-sided Hepatectomy in Type II or IV Perihilar Cholangiocarcinoma

    • Seung Soo Hong
    • Dai Hoon Han
    • Gi Hong Choi

    Hepatobiliary Tumors 10 November 2022 Pages: 1381 - 1390

    

26. ASO Visual Abstract: Left-Sided Hepatectomy Leads to Less Postoperative Liver Failure and Comparable Overall Survival to Right-Sided Hepatectomy in Type II or IV Perihilar Cholangiocarcinoma

    • Seung Soo Hong
    • Dai Hoon Han
    • Gi Hong Choi

    Aso Visual Abstract 17 December 2022 Pages: 1391 - 1391

27. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    Hepatobiliary Tumors 16 November 2022 Pages: 1392 - 1403

    

28. ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    ASO Author Reflections 14 November 2022 Pages: 1404 - 1405

29. ASO Visual Abstract: Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma

    • Laura Alaimo
    • Zorays Moazzam
    • Timothy M. Pawlik

    Aso Visual Abstract 30 November 2022 Pages: 1406 - 1407

30. Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma

    • Shingo Shimada
    • Tayseer Shamaa
    • Shunji Nagai

    Hepatobiliary Tumors 25 November 2022 Pages: 1408 - 1419

    

31. ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation

    • Shingo Shimada
    • Marwan Abouljoud
    • Shunji Nagai

    Aso Author Reflections 13 January 2023 Pages: 1420 - 1421

32. ASO Visual Abstract: Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients With Hepatocellular Carcinoma

    • Shingo Shimada
    • Tayseer Shamaa
    • Shunji Nagai

    Aso Visual Abstract 10 December 2022 Pages: 1422 - 1423

33. Lymph Node Examination and Patterns of Nodal Metastasis Among Patients with Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma After Major Curative-Intent Resection

    • Xu-Feng Zhang
    • Feng Xue
    • Timothy M. Pawlik

    Hepatobiliary Tumors 18 November 2022 Pages: 1424 - 1433

    

34. ASO Author Reflections: Lymph Node Examination and Patterns of Nodal Metastasis of Left- Versus Right-Sided Intrahepatic Cholangiocarcinoma

    • Xu-Feng Zhang
    • Timothy M. Pawlik

    ASO Author Reflections 15 November 2022 Pages: 1434 - 1435

35. Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer

    • Phillip M. Kemp Bohan
    • Shu-Ching Chang
    • Daniel W. Nelson

    Pancreatic Tumors 02 December 2022 Pages: 1436 - 1448

    

36. ASO Author Reflections: The Complexity of the Volume–Outcome Relationship in Pancreatic Cancer

    • Phillip M. Kemp Bohan
    • Daniel W. Nelson

    Aso Author Reflections 07 December 2022 Pages: 1449 - 1450

37. ASO Visual Abstract: Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer

    • Phillip M. Kemp Bohan
    • Shu-Ching Chang
    • Daniel W. Nelson

    Aso Visual Abstract 27 December 2022 Pages: 1451 - 1452

38. The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas—From Prevalence to Early Cancer Detection

    • Tommaso Pollini
    • Paul Wong
    • Ajay V. Maker

    Pancreatic Tumors Open access 04 January 2023 Pages: 1453 - 1462

39. Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study

    • Eran van Veldhuisen
    • Sjors Klompmaker
    • on behalf of the Scientific Committee of the European-African Hepato-Pancreato-Biliary Association

    Pancreatic Tumors Open access 20 December 2022 Pages: 1463 - 1473

    

40. The Impact of Additional Para-aortic Dissection During Pancreaticoduodenectomy for Resectable Pancreatic Cancer

    • Ziyun Shen
    • Haoda Chen
    • Baiyong Shen

    Pancreatic Tumors 28 October 2022 Pages: 1474 - 1482

    

41. ASO Author Reflections: The Clinical Dilemma of Para-Aortic Dissection in Pancreaticoduodenectomy for Ductal Adenocarcinoma

    • Ziyun Shen
    • Haoda Chen
    • Baiyong Shen

    ASO Author Reflections 27 October 2022 Pages: 1483 - 1484

42. Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium

    • Ifeanyichukwu Ogobuiro
    • Amber L. Collier
    • Jashodeep Datta

    Pancreatic Tumors 31 October 2022 Pages: 1485 - 1494

    

43. ASO Author Reflections: Racial Disparities in Chemoresponsivity in Localized Pancreatic Cancer: Nature or Nurture?

    • Caitlin A. Hester
    • Ifeanyichukwu C. Ogobuiro
    • Jashodeep Datta

    ASO Author Reflections 19 November 2022 Pages: 1495 - 1497

    

44. ASO Visual Abstract: Racial Disparity in Pathologic Response Following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer–A Multi-institutional Analysis from the Central Pancreatic Consortium

    • Ifeanyichukwu Ogobuiro
    • Amber L. Collier
    • Jashodeep Datta

    Aso Visual Abstract 23 December 2022 Pages: 1498 - 1499

45. Superior Mesenteric Artery First Approach for Minimally Invasive Pancreaticoduodenectomy: A Step-By-Step Surgical Technique Video

    • Benedetto Ielpo
    • Alessandro Anselmo
    • Edoardo Rosso

    Pancreatic Tumors 05 November 2022 Pages: 1500 - 1503

46. ASO Author Reflections: Superior Mesenteric Artery Dissection for Minimally Invasive Pancreaticoduodenectomy: A Technique That All Surgeons Should be Familiar With

    • Benedetto Ielpo
    • Alessandro Anselmo
    • Edoardo Rosso

    ASO Author Reflections 19 November 2022 Pages: 1504 - 1505

47. ASO Visual Abstract: Superior Mesenteric Artery-First Approach for Minimally-Invasive Pancreaticoduodenectomy: A Step-by-Step Surgical Technique Video

    • Benedetto Ielpo
    • Alessandro Anselmo
    • Edoardo Rosso

    Aso Visual Abstract 22 December 2022 Pages: 1506 - 1507

48. Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer: A Difference-in-Difference Analysis

    • Sarah P. Huepenbecker
    • Shuangshuang Fu
    • Larissa A. Meyer

    Gynecologic Oncology 30 October 2022 Pages: 1508 - 1519

49. ASO Visual Abstract: Medicaid Expansion and Postoperative Mortality in Women with Gynecologic Cancer—A Difference-in-Difference Analysis

    • Sarah P. Huepenbecker
    • Shuangshuang Fu
    • Larissa A. Meyer

    ASO Visual Abstract 26 October 2022 Pages: 1520 - 1521

50. Survival Outcomes of Sublobectomy and Lobectomy in Elderly Patients with Peripheral Solid-Dominant Non-small Cell Lung Cancer

    • Sikai Wu
    • Zimin Wang
    • Jianfei Shen

    Thoracic Oncology 15 December 2022 Pages: 1522 - 1529